Photo:Emily Boja, Ph.D.

Emily Boja, Ph.D.

FDA |
Emily.Boja@fda.hhs.gov

Dr. Boja is a health scientist who will support OHI’s precisionFDA initiative and other informatics endeavors. Prior to joining OHI, she was a Program Director at the Office of Cancer Clinical Proteomic Research, NCI, NIH, providing scientific expertise and leadership in managing the Clinical Proteomic Tumor Analysis Consortium program.